ViiV Healthcare data show lower rates of steatotic liver disease after switching to Dovato - PharmaTimes PASO DOBLE sub‑analysis indicates metabolic differences between 2‑drug and 3‑drug HIV regimens

#virology #ViiVHealthcare #steatoticliverdisease #Dovato #2drugHIVregimens #3drugHIVregimens #PASODOBLEstudy #HIV1 #HIV #Biktarvy #ConferenceonRetrovirusesandOpportunisticInfections2026 #HIVinnovation #metabolichealthoutcome #longtermHIVtreatment
zurl.co/ESlts

What are 9 key Dovato side effects to watch out for? Official answer: Key Points Dovato (dolutegravir and lamivudine) is a once-daily combination medication that may be given to treat HIV-1...

#Dovato: once-daily HIV-1 treatment (dolutegravir + lamivudine) for ages 12+ who weigh ≥25kg. Common side effects: lab abnormalities, headache, nausea, diarrhea, insomnia, fatigue. Rare but serious: allergic reactions, liver damage, immune reconstitution syndrome.